New

Ask Wove anything about tariffs.

Try Tariff Assistant

Trastuzumab (Herceptin) Infusion Vial from China

Trastuzumab is a humanized monoclonal antibody against HER2 protein, used in HER2-positive breast cancer therapy. Classified under HTS 3002.15.00.11 for its immunological role in targeted cancer treatment, supplied in measured dose vials for retail pharmacy sale.

Duty Rate — China → United States

100%

Rate breakdown

9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter

Import Tips

• Provide FDA import permit and lot-specific stability data; maintain 2-8°C throughout shipping

• Label clearly as 'contains monoclonal antibodies' with biotech process details to match HTS description

• Watch for duty-free claims under GSP; pitfall is incomplete biotech modification documentation

Trastuzumab (Herceptin) Infusion Vial from China — Import Duty Rate | HTS 3002.15.00.11